1. |
周东辉,马志敏,周杏仁,等. 上皮钙粘附素的表达与胃癌分化程度及预后的关系 [J]. 浙江医学,2000; 22(10)∶577.
|
2. |
Nakajo A, Natsugoe S, Ishigami S, et al. Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer [J]. Ann Surg Oncol, 2001; 8(2)∶158.
|
3. |
Chan AO, Lam SK, Chu KM, et al. Soluble Ecadherin is a valid prognostic marker in gastric carcinoma [J]. Gut, 2001; 48(6)∶808.
|
4. |
Hamazoe R, Koga S, Maeta M, et al. Levels of tissue polypeptide antigen in serum and the progression of gastric cancer [J]. J Surg Oncol, 1989; 41(2)∶128.
|
5. |
Abbasciano V, Levato F, Zavagli G. Specificity of carcinoembryonic antigen, gastrointestinal cancerassociated antigen, tissue polypeptide antigen, fibrinopeptide A and gammaglutamyl transferase in the diagnosis and followup of gastric cancer [J]. Oncology, 1988; 45(3)∶159.
|
6. |
田建华,张肖楠,任锡玲,等.胃癌患者可溶性白细胞介素2受体与肿瘤坏死因子α水平的临床观察 [J]. 中华消化内镜杂志,1998; 15(4)∶224.
|
7. |
Saito H, Tsujitani S, Ikeguchi M, et al. Serum level of a soluble receptor for interleukin2 as a prognostic factor in patients with gastric cancer [J]. Oncology, 1999; 56(3)∶253.
|
8. |
Konno S, Takebayashi Y, Aiba M, et al. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma [J]. Cancer Lett, 2001; 166(1)∶103.
|
9. |
Ozercan IH, Bahcecioglu IH, Ozercan MR, et al. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies [J]. Indian J Gastroenterol, 2000; 19(2)∶57.
|
10. |
耿明,高振华,郝支军,等. PCNA在胃粘膜肠上皮化生、异型增生和胃癌中的表达及意义 [J]. 中国肿瘤临床与康复,2000; 7(3)∶3.
|
11. |
裘华森,张成武,邹寿椿,等. 胃癌增殖细胞核抗原表达的临床意义[J]. 浙江医学,1999; 21(7)∶385.
|
12. |
吴泰璜,申泮远,苏忠学,等. 血管内皮生长因子在胃癌中的表达及其与血管生成和细胞增殖的关系 [J]. 中华实验外科杂志,2000; 17(1)∶42.
|
13. |
Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma [J]. Cancer Lett, 2000; 153(12)∶7.
|
14. |
Soman NR, Correa P, Ruiz BA, et al. The TPRMET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions [J]. Proc Natl Sci USA, 1991; 88∶4892.
|
15. |
庄小强,郑杰,林三仁, 等. cmet 蛋白表达与胃粘膜病变的关系及预后意义 [J]. 中华病理学杂志, 2000; 29(6)∶409.
|
16. |
Amemiya H, Kono K, Mori Y, et al. High frequency of cmet expression in gastric cancers producing alphafetoprotein [J]. Oncology, 2000; 59(2)∶145.
|
17. |
刘玉龙,石琳,高丽丽,等. 胃癌VEGF和nm23表达与血管生成的关系及其临床意义 [J]. 实用肿瘤杂志,2000; 15(5)∶312.
|
18. |
KumarDhar D, Kubota H, Tabara H, et al. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFPproducing carcinoma [J]. Oncology, 1999; 56(2)∶122.
|
19. |
Yagihashi A, Kameshima H, Yajima T, et al. The significance of telomerase activity in patients with gastric cancer [J]. Rinsho Byori, 1998; 46(1)∶5.
|
20. |
贾汝梅,张玉印,宋伟庆,等. 胃癌与端粒酶活性表达及DNA倍体关系的研究 [J]. 中国胃肠外科杂志,2000; 3(2)∶88.
|